ArticleHeliyon2023

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience.

Nicola Schiano Moriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.